F-star Therapeutics, Inc. (FSTX)
NASDAQ: FSTX · IEX Real-Time Price · USD
6.39
+0.03 (0.47%)
Jun 24, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
21.17 | 11.26 | 28.32 | 0 | 0 | 0.35 | 0.95 | 0.74 |
|
Revenue Growth (YoY)
|
88.05% | -60.26% | - | - | - | -62.79% | 28.18% | - |
|
Gross Profit
|
21.17 | 11.26 | 28.32 | 0 | 0 | 0.35 | 0.95 | 0.74 |
|
Selling, General & Admin
|
23.13 | 19.51 | 15.28 | 8.72 | 8.18 | 5.74 | 5 | 2.41 |
|
Research & Development
|
28.75 | 14.13 | 31.39 | 19.75 | 13.08 | 14.02 | 7.54 | 6.13 |
|
Other Operating Expenses
|
0 | 0 | 4.15 | 0 | 0 | 0 | 0 | 0 |
|
Operating Expenses
|
51.88 | 33.64 | 50.82 | 28.47 | 21.25 | 19.76 | 12.54 | 8.54 |
|
Operating Income
|
-30.71 | -22.39 | -22.5 | -28.47 | -21.25 | -19.4 | -11.6 | -7.81 |
|
Interest Expense / Income
|
0.84 | 1 | 0 | 0 | 0 | 0 | 0 | 1.91 |
|
Other Expense / Income
|
0.1 | 2.23 | 1.25 | -5.62 | 6.43 | -2.04 | -0.03 | -0 |
|
Pretax Income
|
-31.66 | -25.62 | -23.75 | -22.85 | -27.68 | -17.37 | -11.56 | -9.71 |
|
Income Tax
|
-0.37 | -0 | -0.74 | 0 | 0 | 0 | 0 | 0 |
|
Net Income
|
-31.28 | -25.62 | -23.01 | -22.85 | -27.68 | -17.37 | -11.56 | -9.71 |
|
Net Income Common
|
-31.28 | -25.62 | -23.01 | -22.85 | -27.68 | -17.37 | -11.56 | -9.71 |
|
Shares Outstanding (Basic)
|
17 | 3 | 2 | 4 | 3 | 2 | 1 | 1 |
|
Shares Outstanding (Diluted)
|
17 | 3 | 2 | 4 | 3 | 2 | 1 | 1 |
|
Shares Change
|
529.83% | 71.06% | -57.72% | 31.07% | 53.70% | 27.69% | 82.24% | - |
|
EPS (Basic)
|
-1.88 | -9.69 | -14.89 | -6.36 | -9.92 | -9.56 | -8.12 | -12.44 |
|
EPS (Diluted)
|
-1.88 | -9.69 | -14.89 | -7.52 | -9.92 | -9.56 | -8.12 | -12.44 |
|
Free Cash Flow Per Share
|
-1.68 | -6.14 | -14.31 | -7.58 | -6.46 | -8.84 | -6.05 | -9.53 |
|
Gross Margin
|
100.00% | 100.00% | 100.00% | - | - | 100.00% | 100.00% | 100.00% |
|
Operating Margin
|
-145.10% | -198.87% | -79.44% | - | - | -5512.50% | -1225.79% | -1057.72% |
|
Profit Margin
|
-147.79% | -227.60% | -81.26% | - | - | -4933.52% | -1222.41% | -1315.99% |
|
Free Cash Flow Margin
|
-131.86% | -144.15% | -78.07% | - | - | -4554.55% | -909.09% | -1007.05% |
|
Effective Tax Rate
|
1.18% | 0.00% | 3.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
EBITDA
|
-30.17 | -23.48 | -22.91 | -22.57 | -27.52 | -17.25 | -11.48 | -7.76 |
|
EBITDA Margin
|
-142.53% | -208.56% | -80.88% | - | - | -4900.00% | -1213.11% | -1051.90% |
|
Depreciation & Amortization
|
0.64 | 1.14 | 0.84 | 0.29 | 0.16 | 0.12 | 0.09 | 0.04 |
|
EBIT
|
-30.81 | -24.62 | -23.75 | -22.85 | -27.68 | -17.37 | -11.56 | -7.81 |
|
EBIT Margin
|
-145.56% | -218.72% | -83.86% | - | - | -4933.52% | -1222.41% | -1057.59% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).